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Background: The six minute walk test (6MWT) is the most commonly used exercise
test in pulmonary rehabilitation; however, the paucity of six minute walk distance
(6MWD) reference values from population-based samples limits data interpretation
in patients. This study was undertaken to determine 6MWD in a population-based
sample of healthy subjects and to identify predictors of 6MWD in this group.
Methods: Seventy Caucasian subjects (33 males) aged 55–75 years performed three
tests using a standardised protocol. 6MWD was defined as the greatest distance
achieved from the three tests. Other measurements included height, leg length,
weight, forced expiratory volume in 1 s (FEV1), exhaled carbon monoxide and self-
reported physical activity including habitual walking.
Results: The average 6MWD was 659762m (range 484–820m). Males walked 59713m
further than females (Po0:001). Height (r ¼ 0:54, Po0:01), weight (r ¼ 0:25, Po0:05)
and FEV1 (r ¼ 0:48, Po0:001) were significantly correlated with 6MWD. Forwards
stepwise multiple regression showed height (R2 ¼ 0:294) and FEV1 (R2 change ¼ 0.045)
to be independent predictors of 6MWD (Po0:05), explaining 33.9% of the variance.
Conclusions: 6MWD in this healthy population-based sample of males and females
exceeds values previously reported. Height and FEV1 were identified as significant
independent predictors of 6MWD in this group.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
Physiotherapy, Curtin University of Technology, Perth, Western Australia, Australia. Tel.:
du.au (S. Jenkins).
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The six minute walk test (6MWT) is the most
frequently used exercise test in pulmonary rehabi-
litation and is considered to provide a reliable and
valid measure of functional exercise capacity.1–3
Despite the popularity of the 6MWT there is limited
data relating six minute walk distance (6MWD) in
patients with lung disease to that of healthy
subjects. The paucity of 6MWD reference values
from population-based healthy subjects limits the
interpretation of 6MWD in patients and poses
problems for clinicians wishing to provide patients
with a measure of their expected 6MWD in the
absence of disease.
To date, four studies have determined regression
equations to predict 6MWD in healthy popula-
tions.4–7 However, the universal application of
these reference values is limited due to differences
in the population studied and 6MWT protocol. In
two studies5,6 subjects were drawn from a conve-
nience sample which can introduce bias. Perform-
ing a single 6MWT, as was done in two of the
studies,4,7 will underestimate 6MWD, as repeated
testing is required to account for the effect of
familiarisation on the distance walked by both
healthy subjects and patients with chronic obstruc-
tive pulmonary disease (COPD).5,6,8–12 Course
length, pre-test instructions and the frequency of
encouragement also differed between the studies.
Taken together, these differences highlight the
need to determine 6MWD in a healthy population-
based sample following a standardised protocol.
This study sought to determine 6MWD in a
healthy population-based sample of males and
females. As the majority of patients with COPD
undergoing pulmonary rehabilitation are aged
55–75 years, only individuals falling within this
age range were studied. The study also aimed to
identify factors which could predict 6MWD. Most
previous studies have shown that age, gender,
height and weight account for between 19% and
42% of the variability in 6MWD.4,6,7,12 In addition to
these variables, we included measures of leg
length, exhaled carbon monoxide,13 forced expira-
tory volume in 1 s (FEV1), and habitual walking
activity as potential predictors of 6MWD.Methods
Subjects
A population-based sample of healthy males and
females were recruited from a database of researchvolunteers established by the Centre for Asthma,
Allergy and Respiratory Research (Perth, Western
Australia) for genetic studies. Volunteers were
included in the database following postal requests
mailed to randomly selected individuals (using the
program Marketing Pro, DtMS, Blackburn, Victoria,
Australia) listed in the telephone directory of a
state capital city (Perth, Western Australia, popu-
lation 1.3 million). All volunteers underwent an
interview to confirm their healthy status and
spirometry testing at the time of recruitment to
the database.Screening
Subjects were considered for the study if they were
aged 55–75 years and had no documented cardio-
pulmonary disease. Exclusion criteria were abnor-
mal lung function (FEV1o80% predicted [pred] or
FEV1/forced vital capacity [FVC]o70%); medica-
tions affecting exercise capacity; hypertension
(blood pressure4150/100mmHg); diabetes melli-
tus; recent illness including upper respiratory tract
infection or the presence of any factor that may
limit ability to participate in the 6MWT (e.g.
impaired cognitive function, neuromuscular dis-
ease, claudication, severe musculoskeletal pro-
blems affecting the lower extremity or spine or
use of a walking aid).
An information sheet was mailed to 168 con-
secutive non-asthmatic individuals listed on the
database. Twenty-five individuals were unable to
be contacted and 37 declined to participate. The
remaining 106 individuals agreed to participate in
the study and were contacted by telephone to
determine suitability for inclusion. Thirty-three
were subsequently excluded due to the presence
of cardiovascular disease (n ¼ 15), osteoarthritis
(n ¼ 9), respiratory disease (n ¼ 4) and other
illness (n ¼ 5). Seventy-three subjects attended
for assessment, of whom a further two were
excluded due to abnormal lung function and one
subject failed to comply with the 6MWT protocol.
Thus, the study population comprised 70 healthy
subjects, all were of Caucasian origin and 33 were
males. Approval for the study was granted by the
Human Research Ethics Committees at Sir Charles
Gairdner Hospital and Curtin University of Technol-
ogy. Written, informed consent was obtained from
each subject prior to testing.Procedure
Data collection took place over a 4-month period
with each subject attending on a single occasion.
Subjects were asked to avoid caffeine, alcohol and
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to testing and strenuous physical exercise in the
previous 24 h.
Smoking history and blood pressure were re-
corded. Weight and height were measured and used
to calculate body mass index (BMI). Leg length for
the right and left leg was measured14 and mean leg
length was used in subsequent analyses. Lung
function was measured in accordance with the
recommendations of the American Thoracic So-
ciety15 using a Vitalograph wedge bellows spirom-
eter (Model S, Vitalograph Ltd., Buckingham, UK).
Exhaled carbon monoxide was measured in dupli-
cate using an EC50 Micro Carbon Monoxide Monitor
(Micro Medical Ltd., Southampton, UK). This
monitor provides a conversion to percentage of
carboxyhaemoglobin (COHb) and the higher of the
two measurements was recorded.
Subjects completed a Physical Activity Question-
naire16 to determine the amount of physical
activity performed in the previous week, or another
recent week if the last week was atypical. Ques-
tionnaire responses were used to classify subjects
as undertaking sufficient physical activity, insuffi-
cient physical activity for health benefits, or
inactive using the definitions from the Survey of
Physical Activity Levels of Western Australian
Adults 1999.16
Six minute walk test
The 6MWTwas performed over a 45m long straight
course within an enclosed level corridor. To allow
familiarisation with the protocol, subjects per-
formed the test three times separated by 20min
rest intervals. The same investigator (BC) super-
vised all tests. The temperature of the corridor was
25.871.5 1C and humidity was below 55% during
all tests.
Taped standardised instructions (modified from
Sciurba and Slivka9) were played to subjects prior
to each 6MWT. Subjects were told to ‘‘walk as
quickly as you can for six minutes so that you cover
as much ground as possible.’’ They were informed
that they could slow down or rest if necessary. At
the end of each minute subjects were given
feedback on the elapsed time and standardised
encouragement in the form of statements such as
‘‘you’re doing well, keep it up’’ and ‘‘do your
best.17’’
Measures
Heart rate (HR) was recorded at rest and at the end
of each minute during the 6MWTusing a lightweight
telemetric HR monitor (Polar Electro Oy, Kempele,
Finland). Oxygen saturation (SpO2) was recorded
prior to and upon completion of the 6MWT using anoximeter and finger sensor (Ohmeda Biox 3700e,
Ohmeda, Colorado, USA). At the end of the test,
the distance was measured and, where applicable,
leg fatigue was rated using a modified Borg 0–10
scale.18
During the 20min rest between consecutive tests
subjects were provided with a glass of water and
asked to remain seated. HR was re-measured at the
end of the rest period to ensure that it was within
10 beats per minute (bpm) of the previous resting
value and where necessary the rest period was
extended.Statistical analyses
Data were checked for distribution and means
and standard deviations calculated. All data were
normally distributed with the exception of FEV1/
FVC, COHb and minutes walked in the previous
week. Acceptable normalisation of these variables
was achieved with a square root transformation.
A one-way repeated measures ANOVA with con-
trasts was used to compare the three 6MWD’s.
Reproducibility of the 6MWD was examined using
intraclass correlation coefficient (ICC) and coeffi-
cient of variation (CV).
Maximum 6MWD from the three tests was
identified for each subject and used in the
following analyses. Unpaired t-tests were per-
formed to determine differences in subject char-
acteristics and 6MWD between males and females.
Pearson’s univariate correlation coefficients (r)
were computed to examine the association be-
tween subject characteristics and 6MWD. Forward
stepwise multiple regression was used on the
variables height, age, weight, gender, leg length,
FEV1 (L) and minutes walked in the previous week
to determine their contribution to 6MWD.
The 6MWD measured in our study was compared
with predicted 6MWD derived from three published
equations4–6 using scatter plots and paired t-tests.
Comparisons were made of maximum 6MWD ob-
tained from an equivalent number of tests where
possible. Specifically, when comparing our data to
that of Enright and Sherrill4 and Troosters et al.5 we
used the 6MWD from the first test and the best of
the first and second tests, respectively. The
maximum 6MWD from the three tests in each
subject was compared to the data of Gibbons
et al.6 whose subjects performed four tests. No
comparison was made with the most recently
published reference equation7 as subjects in the
study were aged 7774 years.
Analyses were performed using the SPSS compu-
ter package (Version 11). An alpha value of 0.05
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reported as mean7standard deviation (SD).Results
Subject characteristics
The characteristics of the 70 subjects (33 males)
are summarised in Table 1. The majority of subjects
(63%) were overweight or obese. Sixty-three sub-
jects (90%) were classified as undertaking sufficient
physical activity for health benefits.16 The subjects
had a high level of education, with 37 subjects
(53%) having attended a vocational training college
or university. In eight subjects COHb levels were
above the normal range. Males were taller by
10.171.5 cm (Po0:001); however, there was no
significant difference in leg length between malesTable 1 Characteristics of the 70 healthy subjects.
Characteristic
Males/females
Age (years)
55.0–64.9
65.0–75.0
Height (cm)
Leg length (cm)
Weight (kg)
BMI (kg/m2)
Normal (20–24.9)
Overweight (25–29.9)
Obese (X30)
FEV1 (L)
% pred FEV1
FVC (L)
% pred FVC
FEV1/FVC (%)
COHb (%)
Resting HR (bpm)
Minutes walked prev wk
Physical activity level16
Sufficient
Insufficient
Inactive
Smoking history
Smoker
Ex-smoker
Non-smoker
Pack years
BMI: body mass index; FEV1: forced expiratory volume in 1 s; FVC:
rate; SpO2: oxygen saturation; Prev wk: previous week.
Pack years are calculated for smokers and ex-smokers. COHb cat
smoker.and females (88.076.5 cm vs 85.377.0 cm,
P ¼ 0:11). There were also no significant differ-
ences between the males and females in BMI,
minutes walked in the last week, physical activity
levels and smoking history.Six minute walk distance
No test was terminated prematurely by the
investigator and no subject required a rest during
the 6MWT. The resting HR prior to commenc-
ing successive tests was not different, being
75.3710.8, 76.6711.0 and 77.7710.8 bpm.
6MWD during tests 1, 2 and 3 was 626763,
645758 and 655761m, respectively. There was a
significant increase in 6MWD between consecutive
tests with subjects walking 18730m (a 3.075.0%
increase, maximum 20.7%) further on the second
test (Po0:001) and 10717m (a 1.672.7% increase,Mean7SD (range) or number/percentages
33/37
64.575.2 (55.1–74.5)
36
34
167.877.9 (151.0–190.0)
86.676.8 (69.0–98.0)
74.3713.0 (48.0–109.8)
26.273.5 (20.2–37.9)
26 (37.1%)
33 (47.1%)
11 (15.7%)
3.0070.69 (1.77–4.69)
116.7718.0 (81.0–160.0)
3.8670.85 (2.44–5.67)
108.5716.2 (73.0–145.0)
77.874.3 (70.0–94.0)
0.870.5 (0.3–3.6)
73.0710.5 (53.0–100.0)
177.87146.3 (0.0–840.0)
63 (90.0%)
6 (8.5%)
1 (1.5%)
2 (2.8%)
29 (41.5%)
39 (55.7%)
22.5726.2
forced vital capacity; COHb: carboxyhaemoglobin; HR: heart
egories: 0–0.8 non-smoker; 1–1.6 light smoker; 1.8–12 heavy
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(Po0:001). Distances walked on tests 1, 2 and 3
were 652758, 669749 and 685749m in the
males, and 603760, 623757 and 628759m in
females. Analysis by gender showed the increase
between the second and third test was significant
for males only (males 16720m, P ¼ 0:03; females
5712m, P ¼ 0:07). The number of subjects achiev-
ing their maximum distance on the first, second and
third test was 4, 15 and 51, respectively. The ICC
for the three tests was 0.84 and the CV was 2.9%
(range 0.23–11.0%).
The overall maximum 6MWD (best of the three
tests) was 659762m (range, 484–820m) and was
greater in males than females by 59713m
(Po0:001), being 690753 and 631757m in males
and females, respectively.
Heart rate, oxygen saturation and leg
symptoms
Peak HR was 135720 bpm (87713% predicted
maximum HR [220-age]) on the best of the three
tests with 39 subjects exceeding 85% of predicted
maximum HR (HRmax). There were no significant
differences in pre- and post-test SpO2 (96.771.1%
vs. 96.671.34%, P ¼ 0:09). Fifteen subjects re-
ported leg fatigue (score 40) at the end of the
6MWT.
Associations with six minute walk distance
Univariate correlation coefficients between 6MWD
and subject variables are presented in Table 2.
Significant correlations were observed with height,
weight and FEV1 but not with age, leg length, BMI,
COHb or minutes walked in the previous week.
Predictors of six minute walk distance
Forward stepwise multiple regression analysis
revealed that height and FEV1 were significant
independent predictors (Po0:05) and together
explained 33.9% of the variability in 6MWD.Table 2 Univariate correlation coefficients (r) for 6MWD
Age
(years)
Height
(cm)
Leg length
(cm)
Weig
(kg)
6MWD (m) 0.03 0.54 0.05 0.25
P value NS o0.01 NS o0.
NS: not significant at Po0:05; Mins walked: minutes walked in prThe regression equation for this relationship is:
6MWD(m) ¼ 64.69+3.12 (height, cm)+23.29 (FEV1,
L). Height alone accounted for 29.4% of the
variance and FEV1 explained an additional 4.5% of
the variance in 6MWD. Gender was not a significant
predictor and explained only 2.7% of the variance in
6MWD.
Multiple regression analysis on height, age,
weight and gender, shown to be predictors of
6MWD in other studies,4,5 explained 36% of the
variance in 6MWD. The regression equation for this
relationship is: 6MWD(m) ¼ 216.90+4.12 (height,
cm)1.75 (age, years)1.15 (weight, kg)34.04
(gender, where males ¼ 0 and females ¼ 1).Comparisons with published regression
equations4–6
Figure 1 shows the individual data points for these
comparisons and demonstrates that, regardless of
which equation was used, the predicted 6MWD
tended to underestimate our measured 6MWD.
Group mean 6MWD7SD (95% CI) was underesti-
mated by 119765m (103–134m)4 (Fig. 1a)
ðPo0:01Þ, 19755m (6–32m)5 (Fig. 1b) (Po0:01)
and 22755m (9–35m)6 (Fig. 1c) (Po0:01).Discussion
This study demonstrated that the average 6MWD in
healthy subjects aged 55–75 years recruited from
our database in Western Australia was 659m.
Height and FEV1 were significant independent
predictors of 6MWD and together explained 33.9%
of the variance in 6MWD.
Small but statistically significant improvements
in 6MWD were observed between consecutive tests
and may be explained by test familiarisation which
has been shown to influence intra-subject varia-
bility in 6MWD in both healthy subjects and COPD
patients.3,5,6,8–12 Data comparing the magnitude of
any learning effects in males and females is absent
in COPD patients and scarce in healthy subjects. Inand subject variables (n ¼ 70).
ht BMI
(kg/m2)
COHb
(%)
FEV1 (L) Mins walked
0.07 0.09 0.48 0.13
05 NS NS o0.001 NS
evious week.
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Figure 1 (a) Comparison of measured and predicted 6MWD determined from Enright and Sherrill4 Line of identity is
shown. (b) Comparison of measured and predicted 6MWD determined from Troosters et al.5 Line of identity is shown.
(c) Comparison of measured and predicted determined from Gibbons et al.6 Line of identity is shown.
Six minute walk distance in healthy subjects aged 55–75 years 663our healthy females, the distance plateaued by the
second test but in males 6MWD significantly
increased from test 2 to test 3. The latter finding
is consistent with Wu et al.12 who showed healthy
males required more practice tests than females to
reach a maximal 6MWD. Further improvements in
6MWD may have been achieved in male subjects
with a fourth test; however, the magnitude of any
such increase is likely to be small.6,12 While a
statistically significant gender difference was noted
for 6MWD in our study, the mean increase between
the first and third test for males and females was
small (6.0% and 4.8%, respectively), suggesting thatin studies with large numbers of healthy subjects a
single test may provide a useful representative
measure of 6MWD. It was notable, however, that
the magnitude of increase was large in some
individuals being 23% in both one male and one
female subject. There were no obvious identifying
characteristics in these individuals.Comparison of 6MWD with other studies
Compared to estimated 6MWD using regression
equations from other studies,4–6 the healthy
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The increase was modest when compared to studies
by Troosters et al.5 and Gibbons et al.6 (19 and
22m, respectively), but substantial when com-
pared to the study of Enright and Sherrill4
(119m). It is difficult to explain the large differ-
ence between Enright’s4 results and ours, as both
studies used standardised instructions and encour-
agement, which are important during a self-paced
test such as the 6MWT,17 and the subjects’ age and
anthropometric characteristics were similar in the
two studies. It is possible that the effort levels of
the subjects studied by Enright and Sherrill4 were
submaximal, as HR during their 6MWT (only one
test performed) reached o65% age-predicted
HRmax. This contrasts to a HR of 81% of predicted
maximum attained in our subjects on their first
6MWT, 80% of predicted HRmax achieved on the
first 6MWT in the study by Kervio et al.10 and 77% of
predicted HRmax attained on the best of two
6MWTs (HR for first test not reported) in the study
by Troosters et al.5Predictors of six minute walk distance
Significant positive correlations were found be-
tween 6MWD with height, weight and FEV1 but not
with age, leg length, BMI, COHb or minutes walked
in the previous week. The observed association
between height and weight with 6MWD is consistent
with previous findings.4,5,7 While this is the first
study to report a significant correlation between
6MWD and FEV1 in healthy subjects, Webb et al.
19
recently found an association between FEV1 and
the distance walked on the incremental shuttle
walking test in healthy males.
Height and FEV1 were the only significant
independent predictors of 6MWD, explaining
33.9% of the between-subject variance in 6MWD.
This is comparable to the variance explained
by most other studies in healthy subjects
(19–42%).4,6,7 An exception is the study by Troosters
et al.5 who found that age, height, weight and
gender explained 66% of the variance in 6MWD.
Using the same four variables we were still only
able to account for 36% of the variance in 6MWD.
The reason for the difference is not clear but may
relate to differences in subject characteristics and
the greater range of 6MWD in Troosters et al.5 study
(383–820m) compared to ours (484–820m). Verifi-
cation of our regression equation and 6MWD
achieved by subjects in our study should be under-
taken in a prospective cohort of healthy subjects
recruited using identical inclusion criteria.Age was not a significant predictor of 6MWD, a
finding that contrasts with previous studies.4–7
Stringent exclusion criteria prohibited the partici-
pation of subjects with age-related health pro-
blems that may have adversely affected walking
speed. Some studies have shown that age is not a
significant predictor of walking speed when plantar
flexor strength and the presence of health pro-
blems are taken into consideration,20 suggesting
that pathology associated with ageing rather than
chronological age may account for a greater
proportion of the variation in walking speed during
the 6MWT.20 We anticipated that weight or BMI
would be a significant predictor of 6MWD as excess
weight can influence gait and increase workload.4,7
However, our findings did not support this. This is
most likely because only nine of our subjects had a
BMI430, a value which has been identified as the
upper threshold for a low 6MWD in healthy
subjects.7 Inclusion of subjects with a wider range
of BMI may be necessary to more clearly define the
relationship between BMI and 6MWD. Alternatively,
it may be that other anthropometric variables such
as waist size could account for a greater proportion
of the variability in 6MWD.7
The absence of gender as a predictor of 6MWD is
consistent with the observations of Enright et al.7
who found that after correcting for height, males
did not walk further than females. We chose not to
measure quadriceps strength as it does not appear
to be a predictor of 6MWD in healthy subjects after
correcting for height, weight, age and gender.5
In an attempt to explain a greater proportion of
the variability in 6MWD we assessed the contribu-
tion of leg length, minutes walked in the previous
week and COHb. We hypothesised that leg length
may be a better predictor of 6MWD than height as it
is a primary determinant of stride length.4 How-
ever, this was not supported by our data. We
hypothesised that 6MWD would be greater in
individuals who walked for prolonged periods on a
regular basis. Of particular interest was the time
spent walking for continuous periods of at least
10min either for recreation, exercise or transport.
However, minutes walked in the previous week was
not a predictor of 6MWD. This finding is consistent
with other studies that also failed to demonstrate
an association between self-reported physical
activity and 6MWD.5,6 It is possible that the speed
of habitual walking, which was not assessed in this
study, may be a more relevant predictor of 6MWD
than time spent walking. Since high levels of carbon
monoxide in arterial blood reduce the oxygen
carrying capacity of haemoglobin and may reduce
exercise capacity21, we hypothesised that elevated
levels of COHb may contribute to a lower 6MWD.
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between raised COHb levels and decreased 6MWD.
This is most likely because the selection criteria
required subjects to have normal lung function and
the majority of subjects (89%) had a level of COHb
within the normal range. To more specifically
examine the effect of COHb on 6MWD, a study
with larger sample size, including greater numbers
of current smokers would be required. A greater
proportion of the variability in 6MWD may also be
explained by inclusion of factors such as mood,
attitude, motivation and race, which have also
been shown to influence 6MWD.7,22
In conclusion, this study has shown that 6MWD in
a healthy population-based sample of 55–75-year-
old males and females from Western Australia
exceeds values reported in previous studies. A
prediction equation containing height and FEV1
explained 33.9% of the variance in 6MWD.Acknowledgements
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